🤖 Synthetic biology's Netscape moment
Sequencing, DNA synthesis and CRISPR cost curves are all beating Moore's law, and the Zymergen IPO ($5B on ~$14M of revenue) plus Ginkgo's $15B SPAC are the Netscape moment for programmable biology — the capital markets have opened and an entire generation of synbio companies gets built over the next couple of years, even though today's businesses admittedly aren't good businesses yet.
⚖ Why this verdict
fully deterministic — evaluate.py replays this from daily closes; nothing below is editable or hand-set
- Window: 2021-05-13 → 2023-05-13 — first mention + 24-month horizon, then the window locks.
- The call: ▲ LONG ARKG (primary play). ARKG fell 59.2% over the window → direction-adjusted R = -59.2% (the call lost money).
- Benchmark: holding SPY over the same window returned +3.4% → α = -59.2 − (+3.4) = -62.6% — what this call made or lost against just owning the index. This is the number the verdict uses.
- Rule fired:
· HIT — R ≥ +10% AND α ≥ +5· PARTIAL — R ≥ +5% OR α ≥ 0▶ MISS — everything else
- Credit: supporters of a MISS earn 0 each, opposers the inverse — this feeds the scoreboard weights. supported: nobody | opposed: Chamath, Friedberg
Conviction timeline
bands: green ≥ 65 · watch ≥ 45 · ember ≥ 15
Plays vs SPY · % since first mention (2021-05-13)
Plays
| expression | symbol | kind | relevance | rationale |
|---|---|---|---|---|
| ▲ LONG | ARKG | etf | PRIMARY | the liquid genomics/synbio basket — the tradeable expression of 'biology becomes software' |
| ▲ LONG | DNA | stock | adjacent | Ginkgo Bioworks — the $15B SPAC they discussed by name |
| ▲ LONG | TWST | stock | adjacent | Twist Bioscience — the DNA-printing toolchain layer Friedberg credits for the cost curve |
Mention log
“And I think these two IPOs happening at the valuations that they're happening at and the capital that's going in, I think these are kind of like the Netscape moments for synthetic biology and we're going to see a tremendous amount happen over the next couple of years.”
“This is why Ximergen and Ginkgo are two really important data points. ... And in that, you're going to have an entire generation of companies get built. It's super exciting. I spend time in and around these businesses without getting too specific.”
“And I think that's really a moment that will inspire a whole new realm of industrial synthetic biology work, a lot of which I hope to kind of build and participate in pretty heavily in the work that we do day to day.”
“And I think it speaks to what I highlighted as what will be the new frontier in biotech and will completely rewrite the course of humanity is if we can take drugs and for a short period of time, completely reverse the age of ourselves. ... And this technology and this is going to be the year I think this will be the front cover of a lot of magazines this year. As people realize that this is real and that it's getting commercialized.”
“Whenever I see these grandiose prognostications of future progress and then see these companies raise exorbitant amounts of money, I have never found a single example where it's ever worked ever. In fact, every time I see a company raise an exorbitant amount of money in a Series A, I write them off in my head. ... And in fact, I've never seen a three billion dollar venture fund do much more than return 2X of money.”
“But the industrialization, the amount of capital these guys raised and what they promised they would deliver on when turned out not to quite beat the economics, not to quite get there. And the market decisions they made about what products to go after, how quickly to scale up, building their own facilities. There was just a lot of strategic errors. And I think the storytelling got ahead of where the business was.”
“Hundreds of millions of dollars, and in several cases, billions of dollars have gone into these systems, and it's very likely that these companies may need several more years and several billion dollars. We are going to get there. The technology is progressing. The rate of progress is a little slower, and it's a little more challenged, I think, than the first round of investors had hoped.”
Who built this conviction
each voice's total force on the score — supports and opposes from every mention, weighted exactly as the replay applied them · share = % of all mention-driven movement
⏳ decay drained -44.2 over the idea's life — that's time passing, attributed to no one
Score events
| episode | kind | Δ | after | note |
|---|---|---|---|---|
| E32 2021-05-13 | init | +45.2 | 45.2 | E32 born by Friedberg (explicit_prediction x3) [w=1.08] |
| E32 2021-05-13 | reinforce | +11.1 | 56.4 | E32 Chamath support x2 (new voice) [w=0.90] |
| E33 2021-05-22 | decay | -1.1 | 55.2 | E33 silent |
| E34 2021-05-31 | decay | -1.1 | 54.1 | E34 silent |
| E35 2021-06-13 | decay | -1.1 | 53.1 | E35 silent |
| E36 2021-06-18 | decay | -1.1 | 52.0 | E36 silent |
| E37 2021-06-25 | decay | -1.0 | 50.9 | E37 silent |
| E38 2021-07-03 | decay | -1.0 | 49.9 | E38 silent |
| E39 2021-07-09 | decay | -1.0 | 48.9 | E39 silent |
| E40 2021-07-16 | decay | -1.0 | 48.0 | E40 silent |
| E41 2021-07-23 | decay | -1.0 | 47.0 | E41 silent |
| E42 2021-07-30 | decay | -0.9 | 46.1 | E42 silent |
| E43 2021-08-06 | decay | -0.9 | 45.1 | E43 silent |
| E44 2021-08-28 | decay | -0.9 | 44.2 | E44 silent |
| E45 2021-09-04 | decay | -0.9 | 43.3 | E45 silent |
| E46 2021-09-14 | decay | -0.9 | 42.5 | E46 silent |
| E47 2021-09-18 | decay | -0.8 | 41.6 | E47 silent |
| E49 2021-10-02 | decay | -0.8 | 40.8 | E49 silent |
| E50 2021-10-09 | decay | -0.8 | 40.0 | E50 silent |
| E51 2021-10-16 | decay | -0.8 | 39.2 | E51 silent |
| E52 2021-10-23 | decay | -0.8 | 38.4 | E52 silent |
| E53 2021-10-30 | decay | -0.8 | 37.6 | E53 silent |
| E54 2021-11-06 | decay | -0.8 | 36.9 | E54 silent |
| E55 2021-11-13 | decay | -0.7 | 36.1 | E55 silent |
| E56 2021-11-20 | decay | -0.7 | 35.4 | E56 silent |
| E57 2021-12-04 | decay | -0.7 | 34.7 | E57 silent |
| E58 2021-12-11 | decay | -0.7 | 34.0 | E58 silent |
| E59 2021-12-17 | decay | -0.7 | 33.3 | E59 silent |
| E60 2021-12-23 | reinforce | +10.8 | 44.1 | E60 Friedberg support x2 [w=1.08] |
| E61 2021-12-29 | decay | -0.9 | 43.2 | E61 silent |
| E62 2022-01-08 | decay | -0.9 | 42.4 | E62 silent |
| E63 2022-01-15 | decay | -0.8 | 41.5 | E63 silent |
| E64 2022-01-22 | decay | -0.8 | 40.7 | E64 silent |
| E65 2022-01-29 | reinforce | +9.6 | 50.3 | E65 Friedberg support x2 [w=1.08] |
| E65 2022-01-29 | oppose | -13.0 | 37.2 | E65 Chamath opposes x3 [w=0.90] |
| E66 2022-02-05 | decay | -0.7 | 36.5 | E66 silent |
| E67 2022-02-12 | decay | -0.7 | 35.8 | E67 silent |
| E68 2022-02-19 | decay | -0.7 | 35.1 | E68 silent |
| E70 2022-02-24 | decay | -0.7 | 34.4 | E70 silent |
| E71 2022-03-05 | decay | -0.7 | 33.7 | E71 silent |
| E72 2022-03-19 | decay | -0.7 | 33.0 | E72 silent |
| E73 2022-03-26 | decay | -0.7 | 32.3 | E73 silent |
| E74 2022-04-01 | decay | -0.6 | 31.7 | E74 silent |
| E75 2022-04-09 | decay | -0.6 | 31.1 | E75 silent |
| E76 2022-04-16 | decay | -0.6 | 30.4 | E76 silent |
| E77 2022-04-23 | decay | -0.6 | 29.8 | E77 silent |
| E78 2022-04-30 | decay | -0.6 | 29.2 | E78 silent |
| E79 2022-05-07 | decay | -0.6 | 28.6 | E79 silent |
| E80 2022-05-13 | decay | -0.6 | 28.1 | E80 silent |
| E81 2022-05-23 | decay | -0.6 | 27.5 | E81 silent |
| E82 2022-05-24 | decay | -0.6 | 27.0 | E82 silent |
| E84 2022-06-24 | decay | -0.5 | 26.4 | E84 silent |
| E85 2022-06-30 | decay | -0.5 | 25.9 | E85 silent |
| E86 2022-07-08 | decay | -0.5 | 25.4 | E86 silent |
| E87 2022-07-14 | decay | -0.5 | 24.9 | E87 silent |
| E88 2022-07-22 | decay | -0.5 | 24.4 | E88 silent |
| E89 2022-07-29 | reversal | -14.6 | 9.7 | E89 Friedberg flips |
| E90 2022-08-05 | decay | -0.2 | 9.6 | E90 silent |
| E91 2022-08-13 | decay | -0.2 | 9.4 | E91 silent |
| E92 2022-08-20 | decay | -0.2 | 9.2 | E92 silent |
| E93 2022-08-26 | decay | -0.2 | 9.0 | E93 silent |
| E94 2022-09-01 | decay | -0.2 | 8.8 | E94 silent |
| E95 2022-09-10 | decay | -0.2 | 8.6 | E95 silent |
| E96 2022-09-17 | decay | -0.2 | 8.5 | E96 silent |
| E97 2022-09-23 | decay | -0.2 | 8.3 | E97 silent |
| E98 2022-10-01 | decay | -0.2 | 8.1 | E98 silent |
| E99 2022-10-07 | decay | -0.2 | 8.0 | E99 silent |
| E100 2022-10-14 | decay | -0.2 | 7.8 | E100 silent |
| E101 2022-10-22 | decay | -0.2 | 7.6 | E101 silent |
| E102 2022-10-29 | decay | -0.2 | 7.5 | E102 silent |
| E103 2022-11-05 | decay | -0.1 | 7.3 | E103 silent |
| E105 2022-11-19 | decay | -0.1 | 7.2 | E105 silent |
| E106 2022-12-03 | decay | -0.1 | 7.1 | E106 silent |
| E107 2022-12-10 | decay | -0.1 | 6.9 | E107 silent |
| E108 2022-12-16 | decay | -0.1 | 6.8 | E108 silent |
| E109 2022-12-24 | decay | -0.1 | 6.6 | E109 silent |
| E110 2023-01-06 | decay | -0.1 | 6.5 | E110 silent |
| E111 2023-01-13 | decay | -0.1 | 6.4 | E111 silent |
| E112 2023-01-20 | decay | -0.1 | 6.3 | E112 silent |
| E113 2023-01-27 | decay | -0.1 | 6.1 | E113 silent |
| E114 2023-02-04 | decay | -0.1 | 6.0 | E114 silent |
| E115 2023-02-11 | decay | -0.1 | 5.9 | E115 silent |
| E116 2023-02-17 | decay | -0.1 | 5.8 | E116 silent |
| E118 2023-03-03 | decay | -0.1 | 5.6 | E118 silent |
| E119 2023-03-11 | decay | -0.1 | 5.5 | E119 silent |
| E120 2023-03-17 | decay | -0.1 | 5.4 | E120 silent |
| E121 2023-03-24 | decay | -0.1 | 5.3 | E121 silent |
| E122 2023-03-31 | decay | -0.1 | 5.2 | E122 silent |
| E123 2023-04-07 | decay | -0.1 | 5.1 | E123 silent |
| E124 2023-04-14 | decay | -0.1 | 5.0 | E124 silent |
| E125 2023-04-21 | decay | -0.1 | 4.9 | E125 silent |
| E126 2023-04-28 | oppose | -4.9 | 0.0 | E126 Friedberg opposes x2 (marked reversal; no prior support to flip) [w=1.08] |
| E128 2023-05-12 | decay | · | 0.0 | E128 silent |